Sacramento, CA
Peptide Therapy clinics in Sacramento
Sacramento has a state-capital professional demographic and a robust UC Davis medical influence, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across Midtown, East Sacramento, Folsom, and Roseville range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the UC Davis Health, Sutter, and Dignity Health Mercy network. The scene here skews toward physician-led longevity clinics serving state workers and a large commuter population. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Sacramento clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
Weight Loss & Health Clinic by Embodied Wellness
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
- Testosterone Replacement Therapy (TRT)
Harbor Medical Clinic and Wellness Center
- PRP Therapy
- IV Therapy
- Arthritis Treatment
- Chelation Therapy
- Red Light Therapy
Elixyr Labs
- IV Therapy
- IV Hydration
- Peptide Therapy
- Testosterone Replacement Therapy (TRT)
- Hormone Replacement Therapy (HRT)
Best Life Medical Center
- Vitamin IV Therapy
- IV Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
Dr. John Laura
- PRP Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
- Stem Cell Therapy
truMD
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
- Testosterone Replacement Therapy (TRT)
- NAD IV Therapy
Anti-Aging Medical Solutions
- Vitamin IV Therapy
- Laser Therapy (LLLT)
- Peptide Therapy
- Red Light Therapy
- Hormone Replacement Therapy (HRT)
Parkside Pharmacy Compounding and Wellness Center
- IV Therapy
- Ketamine Therapy
- Peptide Therapy
- Hormone Replacement Therapy (HRT)
Synchronicity Health
- Vitamin IV Therapy
- Ozone Therapy
- IV Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
Regulatory context
A note on California's peptide therapy rules.
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. In 2023 and 2024 the FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list, which restricts 503A compounding pharmacies from sourcing those ingredients for patient-specific prescriptions. Section 503A covers traditional pharmacies; Section 503B covers FDA-registered outsourcing facilities operating under cGMP.
-
California Business and Professions Code Division 2 Chapter 9 (Pharmacy Law)
Governs compounding, licensure, and sourcing under the California State Board of Pharmacy. -
California Code of Regulations Title 16 Section 1735 et seq.
Sets compounding standards for sterile and non-sterile preparations. -
California Business and Professions Code Section 2052
Defines practice of medicine and limits who may prescribe or administer drugs. -
California Naturopathic Doctors Act
Grants licensed NDs limited prescriptive authority under formulary advisory committee rules.
The California State Board of Pharmacy inspects sterile compounding facilities under stringent state rules that often exceed USP 797. The Board has issued citations for sourcing non-compliant bulk ingredients and for office-use stocking that should have flowed through a 503B. Non-resident pharmacies shipping into California must hold a current non-resident permit; the Board publishes disciplinary actions and annual inspection findings. Clinics dispensing from in-office stock of compounded peptides are examined closely.